Related Experiment Videos
Evolving molecular-based targeted therapy for cancer: an exciting field
Benedito Carneiro1, Katy Hsiao, Janardan Khandekar
1Department of Medicine, Kellogg Cancer Care Center, Evanston Northwestern Healthcare, IL 60201, USA.
Comprehensive Therapy
|January 13, 2006
Summary
New molecular biology tools identify cancer targets. This article reviews agents targeting epidermal and vascular endothelial growth factors for cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Drug Development
Background:
- Advancements in molecular biology have revealed novel therapeutic targets within cancer cells.
- Targeted therapies offer a promising avenue for cancer treatment.
Purpose of the Study:
- To discuss the scientific rationale for targeting epidermal growth factor (EGF) and vascular endothelial growth factor (VEGF).
- To review clinical data supporting the use of EGF and VEGF targeting agents in specific cancer types.
Main Methods:
- Review of preclinical and clinical studies.
- Analysis of data from targeted therapy trials.
Main Results:
- Identification of EGF and VEGF as key targets in various cancers.
- Demonstration of clinical efficacy for agents targeting these pathways in selected malignancies.
Conclusions:
- Targeted inhibition of EGF and VEGF pathways is a validated therapeutic strategy in oncology.
- Further research into patient selection and combination therapies is warranted.